Roche to Spend $880M for Production Increases in Biologics

Oct 18, 2013

Drugs.com

Roche announced plans to invest 800 million Swiss francs within its global manufacturing network to increase production capabilities for its biologic medicines over the next five years. The investment will be spread across sites in Penzberg (Germany), Basel (Switzerland), as well as Vacaville and Oceanside (USA). Read the full story